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Background: The majority of beta-defensin family members are exclusively expressed in the epididymis, and some
members have been shown to play essential roles in sperm maturation and fertility in rats, mice and humans.
Therefore, beta-defensins are hypothesized to be potential targets for contraception and infertility diagnosis and
treatment. Clarifying the regulatory mechanisms for the expression of these genes is necessary. Androgen/androgen
receptor (AR) signaling plays an important regulatory role in epididymal structure and function. However, very little
is known about the androgenic regulation on the production and secretion of the epididymal beta-defensins.
Methods: The expression of beta-defensins was detected by quantitative RT-PCR. The androgen dependence of
beta-defensins was determined by bilateral orchiectomy and androgen supplementation. The androgen response
elements (AREs) in the promoters of beta-defensins were identified using the MatInspector software. The binding of
AR to AREs was assayed by ChIP-PCR/qPCR.
Results: We demonstrated that 23 mouse caput epididymal beta-defensins were differentially regulated by androgen/
androgen receptor. Six genes, Defb18, 19, 20, 39, 41, and 42, showed full regulation by androgens. Ten genes, Defb15, 30,
34, 37, 40, 45, 51, 52, 22 and Spag11a, were partially regulated by androgens. Defb15, 18, 19, 20, 30, 34, 37, 39, 41, 42, 22
and Spag11a were associated with androgen receptor binding sites in their promoter or intronic regions, indicating direct
regulation of AR. Six genes, Defb1, 12, 13, 29, 35, and spag11b/c, exhibited an androgen-independent expression pattern.
One gene, Defb25, was highly dependent on testicular factors rather on androgens.
Conclusions: The present study provides novel insights into the mechanisms of androgen regulation on epididymal
beta-defensins, enabling a better understanding of the function of beta-defensins in sperm maturation and fertility.
Keywords: Androgen, Androgen receptor, Epididymis, Beta-defensinsBackground
Beta-defensins are small cationic peptides that exhibit
broad-spectrum antimicrobial properties and contribute
to mucosal immune responses at epithelial sites. Recently,
the complete genome sequences of different species and
computational prediction and experimental verification
have identified 30–50 novel beta-defensin genes in humans,
rats and mice that are organized into gene clusters localized
at specific chromosomes [1,2]. The mRNAs encoding the
majority of beta-defensins are exclusively expressed in
the epididymis [3,4]. Epididymal beta-defensins with* Correspondence: syun163@163.com
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unless otherwise stated.antimicrobial activity [5-7] have been shown to be involved
in epididymal innate immune protection; however, recent
studies have indicated that several of these peptides could
bind to the sperm surface and play novel roles in male re-
productive physiology. Rat Bin1b, which binds to the sperm
head, initiates sperm motility in immature sperm from the
caput epididymidis by a mechanism dependent on calcium
uptake [8]. Likewise, immunization with the Bin1b peptide
induced the production of anti-Bin1b antibodies and re-
sulted in reduced fertility in rats [9]. Defb15, which binds
to the sperm acrosomal region and forms part of the sperm
glycocalyx, is required for sperm motility and male fertility.
The in vivo knockdown of the rat Defb15 gene by RNAi
led to a considerable attenuation of sperm motility and fer-
tility [7]. Studies that include target deletion of Defb15 haveThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sperm and a reduced fertility phenotype [10]. Recent stud-
ies have further enhanced our understanding of the role of
beta-defensins in fertility and sterility. Zhou et al. reported
that the homozygous deletion of a cluster of nine β-
defensin genes (DefbΔ9) in mice resulted in male sterility
[11]. Tollner et al. reported that a common mutation in the
human defensin Defb126 causes reduced sperm penetra-
tion ability and is associated with subfertility [12].
Because of their important functions in sperm matur-
ation and fertility, beta-defensins are receiving more at-
tention and are hypothesized to be potential targets for
diagnosing and treating infertility. Therefore, clarifying
the regulation mechanisms on their expression is greatly
required. However, up to now, very little is known about
the regulation of the production and secretion of epi-
didymal beta-defensins.
Androgen signaling plays an important regulatory role
in epididymal structure and function. Many epididymal
secretory proteins involved in sperm maturation have
been identified as androgen-regulated proteins. The ef-
fects of androgen are mediated through the androgen
receptor (AR), a ligand-inducible nuclear receptor that
regulates the expression of target genes by binding to
androgen response element (ARE) DNA [13]. The identifi-
cation of the beta-defensin transcripts that are regulated
by androgens might be important to help elucidate the
process of sperm maturation. Several beta-defensins have
been reported to be regulated by androgen in different spe-
cies, including rats, monkeys, humans and mice. In mice,
only five beta-defensins, including Spag11a (Bin1b), Defb20,
22, 41, and 42 [14-17], have been shown to be regulated
by androgen. However, the previous study was unable
to determine whether these beta-defensins are direct or
indirect AR targets. Additionally, these previous studies
were focused on the individual beta-defensin genes; a
systematic profile of the androgenic regulation of the
beta-defensin family is lacking.
In the epididymis, the majority of beta-defensins are
abundantly expressed in the caput region, which expresses
high levels of AR and proteins required for sperm matur-
ation. In this study, we systematically investigated androgen
regulation on the expression of beta-defensins in the mouse
caput epididymidis. Additionally, we screened and identi-
fied the AR binding sites associated with some androgen-
regulated beta-defensins, indicating direct AR regulation of
these defensins.
Methods
Castration and androgen replacement
Adult 10-wk-old male C57BL/6 J mice were divided into
the following three groups (six mice/group): an intact
group (no castration), an Oil group (castration + oil) and
a testosterone propionate (TP) group (castration + TP). Themice were castrated bilaterally under sodium pentobarbital
anesthesia. After 7 days of recovery, all of the castrated
mice were divided into two groups: the Oil group and the
TP group. The Oil group was treated with a 100-μl injec-
tion of 90% sesame oil and 10% ethanol. The TP group
was injected with 2.5 mg of TP dissolved in 90% sesame
oil and 10% ethanol once every 24 h, for a total treatment
of 5 mg TP over a 48-h period. The oil and TP were
injected into the peritoneal cavity of the mice. All of the
mice were killed 48 h post-injection, and the caput epi-
didymides (not including the initial segment) from each
group were removed for chromatin immunoprecipitation
(ChIP) or real-time polymerase chain reaction (RT-PCR).
All of the mouse treatments were repeated three times. The
testosterone content of the serum samples was measured
using a radioimmunoassay (RIA). The animal experiments
were conducted by following a protocol approved by the
Institute Animal Care Committee. The protocol conforms
to internationally-accepted guidelines for the humane care
and use of laboratory animals.
ChIP
Three adult male C57BL/6 J mice from each group were
sacrificed, and the caput epididymides were removed,
pooled and finely minced in phosphate-buffered saline
(PBS). After washing twice with PBS, the tissue debris was
cross-linked in 1% formaldehyde at room temperature for
10 min. The debris was pelleted, washed and resuspended
in PBS containing protease inhibitors. The debris was then
disaggregated (maintaining the samples on ice) using a
glass homogenizer with 50 strokes. The nuclei were
collected and sonicated to yield 100-500-bp DNA frag-
ments. The lysates were precleared with protein A
beads (sc-2001, Santa Cruz, USA) at 4°C for 2 h before
an overnight incubation with 4 μg of anti-AR antibody
(H-280, sc-13062, Santa Cruz, USA) or normal rabbit
IgG (sc-2027, Santa Cruz, USA). After 2 h of incubation
with the protein A beads, the chromatin-antibody-beads
complex was washed twice with low salt buffer, twice with
high salt buffer, twice with lithium chloride buffer and
three times with TE buffer. Then, the chromatin was
eluted with elution buffer (1% SDS, 0.1 M NaHCO3)
before the reversal of cross-linking with proteinase K
(Invitrogen, Carlsbad, CA) at 65°C for 4 h. The DNA
was purified by two rounds of phenol-chloroform ex-
traction and ethanol precipitation and was resolved in
an optimal volume of ddH2O.
RNA extraction and quantitative RT-PCR
The total RNA was extracted from the mouse caput
epididymidis (not including the initial segment) using
TRIzol (Invitrogen, Grand Island, USA) according to
the manufacturer’s instructions. One microgram of total
RNA was used to synthesize the first-strand of cDNA with
Table 1 Gene ID, RefSeq accession number and known






defb1 13214 NM_007843.3 AL590630.1, AW260221, BD-1
defb12 77674 NM_152802.3 9230103N16Rik, BD-12
defb13 246083 NM_139223.3 AL590619.7, BD-13
defb15 246082 NM_139222.3 AL590619.5, BD-15
defb18 654460 NM_001039123.1 BD-18, EG654460, mBD-18
defb19 246700 NM_145157.3 BD-19, Defb24, Tdl, mBD-19
defb20 319579 NM_176950.3 RP23-453 K8.4, BD-20, mBD-20
defb22 442835 NM_001002791.2 RP23-453 K8.5, 9230002F21Rik
defb25 654459 NM_001039122.1 RP23-35I8.8, BD-25, mBD-25
defb29 75400 NM_001001444.2 RP23-35I8.1, BD-29, mBD-29
defb30 73670 NM_001039566.2 BD-30, mBD-30
defb34 360211 NM_183035.1 BD-34
defb35 246084 NM_139224.1 BD-35
defb37 353320 NM_181683.2 BD-37
defb39 360214 NM_183038.2 BD-39
defb40 360217 NM_183039.3 BD-40
defb41 77673 NM_183124.3 Bd-41, Defb16
defb42 619548 NM_001034910.3 Defb44
defb45 433490 NM_001037752.2 Defb27;
defb51 100503992 NM_001025353.2 Gm6040, EG574083
defb52 100504014 NM_001177471.1 Gm15056,
spag11a 78128 NM_153115.1 Bin1b, EP2Q, EP2e, Spag11
spag11b/c 546038 NM_001039563.3 Ep2c/h; EG546038; Spag11c/h
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oligo dT under the conditions recommended by the manu-
facturer. Quantitative RT-PCR was performed using SYBR
Green master mix (Toyobo, Japan) with a Rotor-Gene 3000
machine (Corbett Research, Sydney, Australia). The
samples and standard curves were performed in tripli-
cate, and the relative standard curve method was used
to calculate the relative gene expression. A housekeeping
gene, ribosomal protein S2, was included as the endogen-
ous normalization control to adjust for unequal amounts
of RNA. The primers for the defensin genes are listed in
Additional file 1: Table S1.
ChIP-PCR and ChIP-qPCR
ChIP assays were performed on mouse caput epididymides
(n = 3) as described above. Primers were designed to amp-
lify a 90- to 150-bp region surrounding the known binding
peaks. DNA samples from the ChIP preparations were
analyzed using conventional PCR or quantitative PCR
with SYBR Green Master Mix (Toyobo). The primers
are listed in Additional file 2: Table S2.
Bioinformatics
Potential ARE search: The sequences of AR binding
sites were scanned for potential ARE motifs using the
MatInspector software (Genomatix Software GmbH,
Germany) with the default settings. MatInspector utilizes
MatBase Matrix Library 8.1, which is a comprehensive
transcription factor binding site database that is frequently
used to locate DNA sequences. Sequence logos for poten-
tial AREs were constructed using Weblogo (http://weblogo.
berkeley.edu/logo.cgi) with the default settings.
Genomic mapping of ARBSs: The file containing
unique ChIP-seq tags in the WIG format was uploaded
to the UCSC genome browser on the mouse mm9 assembly
(http://genome.ucsc.edu/cgi-bin/hgGateway) using “add
custom tracks”. The distribution of ARBSs around AR
target beta-defensin genes was displayed at optimal
settings in “configure tracks and display”.
Statistical analyses
Three replicates of all data were performed and used to
determine statistical significance. All statistical analyses
were carried out with SPSS13.0 (Chicago, IL, USA).
Data are expressed as the mean ± SD. For determination
of significant differences among groups, one-way analysis
of variance was used. P < 0.05 was considered statistically
significant in all the tests.
Results
Identification of beta-defensin genes expressed in the
caput epididymidis
We focused our study on caput epididymidis and compiled
23 beta-defensin genes expressed in the caput region basedon the literature [4,15,16,18,19]. These genes include Defb1,
12, 13, 15, 18, 19, 20, 22, 25, 29, 30, 34, 35, 37, 39, 40, 41,
42, 45, 51, and 52, Spag11a, and Spag11b/c. The NCBI
Gene ID, the RefSeq accession number and the known
aliases of these genes are listed in Table 1. Some mouse
beta-defensin genes have other aliases or designations; for
example, Defb41 is also known as Defb16, Defb19 is also
known as Defb24, Defb45 is also known as Defb27, Defb42
is also known as Defb44, and Spag11a is also known as
Ep2e, Bin1b or Spag11. In our study, only the official names
provided by mouse genome informatics (MGI) were used.
Androgen regulation of beta-defensin gene expression in
the mouse caput epididymidis
To investigate the transcriptional regulation of beta-defensin
genes, we analyzed the expression of these genes in gonadec-
tomized mice. We performed quantitative RT-PCR analyses
using total RNAs isolated from the caput epididymides of
intact mice and mice that had been bilaterally castrated,
reared for 1 week and then treated with TP or oil. As
shown in Figure 1A, the expression of 16 genes, including
Defb15, 18, 19, 20, 30, 34, 37, 39, 40, 41, 42, 45, 51, 52,
Figure 1 The responsiveness of epididymal beta-defensins to androgen manipulation as revealed by quantitative RT-PCR. RNA samples
were prepared from the caput epididymides of intact mice (Intact) and mice castrated for 7 days and supplemented with oil (Oil) or
testosterone propionate (TP). Different genes showed different responsiveness to androgen. A) The gene expression was fully or partially
dependent on androgen. *: P < 0.01 Oil group versus Intact group; **: P < 0.05 TP group versus Oil group. ***: P < 0.05 TP group versus Intact
group. B) The expression of Defb25 was dependent on testicular factors and not on androgen, whereas the expression of other genes was
independent on testicular factors or androgen. *: P < 0.05 Oil group versus Intact group.
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after castration and oil treatment (p < 0.01), whereas after
TP treatment, the mRNA level of these genes was signifi-
cantly increased compared with the mRNA level after oil
treatment (p < 0.05), indicating the androgenic regulation
of the expression of these genes. The expression levels of
6 genes, Defb18, 19, 20, 39, 41, and 42, were increased and
were approximately consistent with the levels observed
in the intact mice after TP treatment (p > 0.05), indicating
complete regulation by androgens. The expression levels of
ten genes, Defb15, 30, 34, 37, 40, 45, 51, 52, and 22 and
spag11a, were significantly lower after TP treatment com-
pared with the levels in intact mice, indicating partial regu-
lation by androgens (p < 0.05). Six genes, Defb1, 12, 13, 29,
and 35 and spag11b/c, exhibited an androgen-independent
expression pattern (Figure 1B). The expression levels of
these genes did not change notably with castration and
TP treatment, indicating that they are constitutively
expressed in the epididymis, regardless of the presence
of androgen or testicular factors. One gene, Defb25, was
down-regulated by castration, and the expression was not
increased after TP treatment, indicating that its expressionwas highly dependent on testicular factors rather than on
androgens (Figure 1B).
AR direct regulation on target beta-defensins
We previously reported the genome-wide androgen recep-
tor binding sites (ARBSs) in the caput epididymidis using
ChIP-seq [14]. Of 16 androgen regulated beta-defensins, 12
had one or more ARBSs within the region 10 kb upstream
of the transcription start site to 5 kb downstream of the
3′-end of the gene. As shown in Figure 2 and Table 2,
eleven defensin genes were associated with only one
ARBS, whereas Defb19 was associated with two ARBSs.
One ARBS was simultaneously associated with Defb30 and
Defb42, implying the potential dual regulatory functions of
this site. The ARBSs associated with Defb18, 19, 20, 30, 34,
41, 42, and 22 and Spag11a were located upstream of the
cognate transcription start site, the ARBS associated
with Defb15 was located in the downstream of the 3′-end,
and the ARBSs associated with Defb37 and Defb39 were
located in the intronic region.
The 12 ARBSs were searched for potential AREs. As
shown in Table 2, the 10 ARBSs associated with Defb15,
Figure 2 Screenshots of the UCSC genome browser mm9 showing AR binding sites around the AR-target beta-defensin genes. The
figure was generated by uploading the file containing unique ChIP-seq tags in the WIG format to the UCSC genome browser. The upper blue
track shows the tag density, and the AR-target beta-defensin genes are shown at the bottom. The black arrow indicates gene orientation.
Sequence positions and other generic UCSC annotations were removed for clarity. One peak formed by a large amount of localized ChIP-seq tags
represents an AR binding site. Defb19 was associated with two peaks, whereas Defb30 and Defb42 share one peak. Defb18, 34, 39, 41, 20, 15, 37,
and 22 and Spag11a were associated with one peak respectively.
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or more potential AREs, whereas the 2 ARBSs associated
with Defb20, 30 and 42 were not potential AREs. The
sequence logo for the potential ARE motif overrepre-
sented in the above-mentioned 10 ARBSs was generated
based on sequence similarity. As shown in Additional
file 3: Figure S1, the identified potential ARE motif from
10 ARBSs (top panel) was very similar to the estab-
lished consensus canonical ARE in the MatBase database
(bottom panel).
To validate the ChIP-seq results, the ARBSs associated
with androgen-regulated beta-defensins were confirmed
by individual ChIP assays combined with conventional
PCR (ChIP-PCR) or quantitative PCR (ChIP-qPCR). As
shown in Figure 3A, all of the ARBSs were occupied by
AR in the caput epididymidis under physiological con-
ditions. Given that AR recruitment to target DNA is
androgen-dependent, we assessed the androgen depend-
ence of AR recruitment to ARBSs using ChIP-qPCR. AR
binding was abolished after castration and recovered fol-
lowing androgen supplementation (Figure 3B), indicating
that AR occupancy is androgen dependent.
Discussion
The epididymis is an androgen-responsive organ re-
sponsible for sperm maturation and storage. Comparedwith other hormones and testicular factors, androgens
play important regulatory roles in epididymal structure
and function [20]. There is a high level of androgen
receptors in the murine epididymis, and because of the
importance of the epididymidis in the regulation of
sperm maturation, the identification of the transcripts
regulated by androgens might facilitate the elucidation
of the process of sperm maturation [21].
Many members of the beta-defensin family have shown
exclusive expression in the epididymis. Except for the
6-cysteine domain, which is rich in positively charged
amino acids, beta-defensins differ considerably in their
amino acid sequences and target pathogen specificity.
They form an important component of the epididymal
innate immune system and provide protection against
a broad range of pathogens that could invade the male
reproductive tract, including E. coli, S. aureus and C.
albicans [5-7]. Recent research has identified additional
functions for beta-defensins that link the innate and
adaptive immune responses. Beta-defensins cross-talk with
the adaptive immune system by interacting with specific
chemokine and toll-like receptors on immature dendritic
cells and memory T cells resulting in the modulation of
immunocompetent cell responses of the host [22].
Epididymal beta-defensins have evolved to perform
functions other than immunoprotection, such as promoting
Table 2 Characterization of ARBSs associated with androgen regulated epididymal beta-defensins











Spag11a chr8 −1914 upstream 113.6 Yes −1844 CGGCAACTTTCTGTACTTT
−1822 GAAGGACAGAAAGTCCTGT
−1740 GATGGACACTTTGTCCTCT
Defb15 chr8 2842 downstream 49.3 Yes 2726 TCAGCACTTACTGTTCCTG
Defb18 chr1 −6911 upstream 36.9 Yes −7011 GAATCTTTTTATGTTCTCT
−7020 TATGTTCTCTATGTTCTGT
Defb19 chr2 −5979 upstream 32.9 Yes −6075 ATCGATCGCTGTGTTCCCA
−6106 TGGGAGCCACTTGTTCCTT
chr2 −3900 upstream 27.2 Yes −3970 ATGCTATAGTTTGTTCTCA
−4012 TAGGAACAGCTTGGCCTGA
Defb20 chr2 −698 upstream 48.3 No
Defb30 chr14 −4251 upstream 33.2 No
Defb34 chr8 −222 upstream 21.3 Yes −110 ATGGGGTGATTTGTTCTGA
Defb37 chr8 1659 intron 19.0 Yes 1609 AGGGAAAGCTGTGTTCTTG
1555 GATCAAAGCCTTGTTCTTT
1531 CAAGGACACTGTGTGCTGA
Defb39 chr8 1750 intron 40.9 Yes 1647 TGGGCACACAGTGGCCTTG
Defb41 chr1 −7576 upstream 63.6 Yes −7633 CAAGAACACTCTGTGATAT
−7692 CCAGAACAACATGTAACAT
Defb42 chr14 −4893 upstream 33.2 No
Defb22 chr2 −9848 upstream 60.5 Yes −9895 ACAGCATGCTGTGTTCTTC
−9958 TTAGAACAACACGATCTCA
ARBS, androgen receptor binding site; TSS, transcription start site; ARE, androgen response element.
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defensins on the sperm surface. However, little is known
about the hormonal regulation, especially androgenic regu-
lation, of the expression of beta-defensins.
In this study, androgen and AR regulation on caput
epididymal beta-defensins was investigated. Beta-defensins
exhibited different responses to androgen manipulation;
most were regulated by androgen, some were not regu-
lated by androgen or testicular factors, and one, Defb25,
was regulated by testicular factors and not by androgen.
Among the androgen regulated beta-defensin genes,
Defb20, 41, 42 and Spag11a were previously reported
to be regulated by androgen [14-16]; our study further
verified that these genes were direct targets of AR and
had AR binding sites in the proximal promoter regions.
Defb30 was previously shown to be regulated by testicu-
lar factors and not by androgens [16]. In our study,
Defb30 was partially regulated by androgen, and it could
be a direct target of AR. This discordance might be attrib-
uted to the sensitivity of different methods. The previous
study used Northern blot to detect the expression of
Defb30, whereas the current study used quantitative
RT-PCR. Compared with quantitative RT-PCR, Northernblot has a low sensitivity. We reanalyzed the previous data
and found a weak staining signal in the androgen replace-
ment mouse epididymis compared with the castrated
mouse epididymis, although the authors ignored it.
Jalkanen et al. reported that Defb42 was partially
regulated by androgen [15], whereas Oh et al. reported
that Defb42 was regulated by testicular factors and not
by androgen [16]. Our results demonstrated that Defb42
was regulated by androgens. To investigate this dis-
crepancy, we reanalyzed the data from Oh et al. and
determined that the Defb42 in their paper should be
classified as Defb48 based on sequence alignment. Oh et al.
also reported that Defb44 was regulated by androgen;
however, in that paper, Defb44 should be classified as
Defb42 based on the sequence alignment.
AR regulates the expression of target genes by binding
to AREs in the genome. Our previous work has identified
genome-wide AR binding sites in the mouse epididymis,
and in this study, we screened and identified ARBSs associ-
ated with androgen-regulated beta-defensins. These sites
were located in the proximal promoters or intronic regions
of target genes, indicating that their expression is directly
regulated by AR. Consistent with our expectations, potential
Figure 3 AR occupancies on epididymal AR binding sites associated with androgen-regulated beta-defensins as revealed by ChIP-PCR
(A) or ChIP-qPCR (B). A) Input sample (IP) and ChIP samples of anti-AR antibody (AR) or normal IgG (IgG) were analyzed using PCR to confirm
AR binding at eleven epididymal target loci. B) ChIP samples were prepared from the caput epididymidis of intact mice (Intact) and mice
castrated for 7 days and supplemented with oil (Oil) or testosterone propionate (TP) for an additional 2 days. Enrichment folds were calculated
using IgG enrichment as a control. The data are presented as the mean ± SD of three replicates.
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these motifs conformed to consensus sequences that were
highly similar to the established ARE in the MatBase data-
base. However, no potential AREs were identified in the two
ARBSs associated with Defb20 and Defb30/42, suggesting
AR regulation by a tethering mechanism. AR regulation oc-
curs without the direct binding of AR to AREs and likely
through tethered associations of the receptor with its target
genes [23]. For the ARBS associated with Defb30/42, an
AP-2 motif was found in the binding summit. AP-2 has
been reported to be an AR coregulator in the mouse caput
epididymidis [14,24]. Thus, AR might be recruited to the
ARBS by interacting with AP-2. Another possibility that
could not be excluded is that there could be AREs that do
not conform to the consensus sequence in the ARBSs asso-
ciated with Defb20 and Defb30/42. For example, our previ-
ous data showed that noncanonical or half-site-like AREs
were enriched in 38.3% of ARBSs without canonical AREsin the mouse epididymis. Those genes that changed expres-
sion, although were not bound by an AR, might be indirect
AR target genes or might be regulated via long-range regu-
lation (binding outside our defined window).
We tested the androgen responsiveness of Defb22,
which is the mouse orthologue of human Defb126, and
determined that it was partially regulated by androgen.
Our ChIP-qPCR data identified an AR binding site in
the distal promoter region, suggesting that Defb22 was
a direct target of AR. Among the 9 genes deleted by
Zhou et al. [11], four (Defb1, 13, 15, and 35) were tested
in our study. Defb15 was partially regulated by androgen,
whereas the three other defensins (Defb1, 13, 35) were not
regulated by androgen.
The present study provides novel insights into the
mechanisms of androgen regulation on epididymal beta-
defensins. Sperm motility and fertilization capacity have
been reported to be regulated by androgen [20]. Some
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Defb15, might be involved in this regulatory process.
Further studies are needed to clarify the functions of all of
the AR target beta-defensins to help elucidate the molecu-
lar mechanism of sperm maturation and fertility.
Conclusions
The current study demonstrated that 23 beta-defensins
from caput epididymis showed different responsiveness to
androgen, and twelve of them were identified to be dir-
ectly regulated by androgen receptor. These results shed
new light on the mechanisms of androgen/AR regulation
on epididymal gene expression.
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